Duncker Streett & CO Inc Gilead Sciences, Inc. Transaction History

Duncker Streett & CO Inc

$515 Million
Q2 2024

A detailed history of Duncker Streett & CO Inc transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Duncker Streett & CO Inc holds 150 shares of GILD stock, worth $12,572. This represents 0.0% of its overall portfolio holdings.

Number of Shares

150

Previous 550 72.73%

Holding current value

$12,572

Previous $40,000 75.0%

% of portfolio

0.0%

Previous 0.01%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 31, 2024	SELL	$63.15 - $72.88 $25,260 - $29,152	-400 Reduced 72.73%	150 $10,000
Q4 2022 Jan 25, 2023	BUY	$62.32 - $89.47 $24,928 - $35,788	400 Added 266.67%	550 $0
Q1 2022 May 09, 2022	SELL	$57.92 - $72.58 $17,376 - $21,774	-300 Reduced 66.67%	150 $9,000
Q3 2021 Nov 03, 2021	SELL	$67.69 - $73.03 $32,152 - $34,689	-475 Reduced 51.35%	450 $31,000
Q2 2021 Jul 27, 2021	SELL	$63.47 - $69.35 $19,041 - $20,805	-300 Reduced 24.49%	925 $64,000
Q1 2021 Apr 28, 2021	SELL	$60.0 - $68.46 $69,000 - $78,729	-1,150 Reduced 48.42%	1,225 $79,000
Q4 2020 Feb 02, 2021	SELL	$56.65 - $64.55 $36,822 - $41,957	-650 Reduced 21.49%	2,375 $138,000
Q2 2020 Jul 22, 2020	SELL	$72.34 - $84.0 $21,702 - $25,200	-300 Reduced 9.02%	3,025 $233,000
Q1 2020 Apr 27, 2020	BUY	$62.63 - $80.22 $4,759 - $6,096	76 Added 2.34%	3,325 $249,000
Q4 2019 Jan 27, 2020	SELL	$61.62 - $67.78 $81,400 - $89,537	-1,321 Reduced 28.91%	3,249 $211,000
Q3 2019 Oct 31, 2019	BUY	$62.51 - $69.0 $31,380 - $34,638	502 Added 12.34%	4,570 $290,000
Q2 2019 Jul 24, 2019	SELL	$61.87 - $69.38 $36,936 - $41,419	-597 Reduced 12.8%	4,068 $275,000
Q1 2019 Apr 29, 2019	BUY	$62.53 - $70.05 $125 - $140	2 Added 0.04%	4,665 $303,000
Q4 2018 Jan 24, 2019	SELL	$60.54 - $79.0 $36,202 - $47,242	-598 Reduced 11.37%	4,663 $292,000
Q3 2018 Oct 22, 2018	SELL	$71.28 - $78.92 $16,251 - $17,993	-228 Reduced 4.15%	5,261 $406,000
Q2 2018 Jul 23, 2018	BUY	$64.88 - $75.68 $194 - $227	3 Added 0.05%	5,489 $389,000
Q1 2018 Apr 26, 2018	BUY	$72.84 - $88.8 $80,124 - $97,680	1,100 Added 25.08%	5,486 $414,000
Q4 2017 Jan 23, 2018	SELL	$71.15 - $83.52 $66,169 - $77,673	-930 Reduced 17.49%	4,386 $314,000
Q3 2017 Oct 25, 2017	BUY	$72.11 - $85.47 $383,336 - $454,358	5,316	5,316 $431,000

Others Institutions Holding GILD

# of Institutions

1,879

Shares Held

1.02B

Call Options Held

12M

Put Options Held

8.96M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $105B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Duncker Streett & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Duncker Streett & CO Inc with notifications on news.

Account

Duncker Streett & CO Inc Gilead Sciences, Inc. Transaction History